Get the Stockscreener App
49.97
2.12%
-1.08
Overview
News
Price History
Option Chain
Financials
Why AA Down?
Discussions
Forecast
Stock Split
Dividend History
Agilent Technologies Inc stock is traded at $49.97, with a volume of 2.79M.
It is down -2.12% in the last 24 hours and up +6.71% over the past month.
Alcoa is a vertically integrated aluminum company whose operations include bauxite mining, alumina refining, and manufacturing primary aluminum. It is one of the world's largest bauxite miners and alumina refiners by production volume, but sits outside the top-10 aluminum producers, a list dominated by Chinese companies. Profits are closely tied to prevailing commodity prices along the aluminum supply chain.Alcoa was the first mass producer of aluminum, launching the world-changing Hall-Heroult smelting process in the 1880s, making aluminum affordable. It listed as a public company in 1925. In 2016, Alcoa spun off its automotive and aerospace metal parts segment to focus on mining, smelting, and refining. It bought the 40% unowned balance of AWAC in mid-2024.
See More
Previous Close:
$51.05
Open:
$50.32
24h Volume:
2.79M
Relative Volume:
0.51
Market Cap:
$13.19B
Revenue:
$14.00B
Net Income/Loss:
$1.26B
P/E Ratio:
10.25
EPS:
4.8749
Net Cash Flow:
$352.00M
1W Performance:
-0.70%
1M Performance:
+6.71%
6M Performance:
-18.81%
1Y Performance:
+59.70%
1-Day Range:
$49.86
$50.72
1-Week Range:
$49.07
$52.58
52-Week Range:
$30.71
$84.38
Agilent Technologies Inc Stock (AA) Company Profile
Name
Agilent Technologies Inc
Sector
Industry
Phone
412-315-2900
Address
201 ISABELLA STREET, PITTSBURGH, PA
Compare AA vs TMO, DHR, NTRA, IQV, A
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AA
Agilent Technologies Inc
|
49.97 | 13.34B | 14.00B | 1.26B | 352.00M | 4.8749 |
TMO
Thermo Fisher Scientific Inc
|
613.78 | 232.03B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
207.66 | 151.78B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
328.18 | 46.82B | 2.50B | -226.32M | 71.51M | -1.6412 |
IQV
Iqvia Holdings Inc
|
267.77 | 42.15B | 16.63B | 1.39B | 2.12B | 8.0674 |
A
Agilent Technologies Inc
|
150.86 | 44.14B | 7.23B | 1.41B | 1.09B | 4.979 |
Agilent Technologies Inc Stock (AA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-09-26 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Mar-13-26 | Upgrade | JP Morgan | Underweight → Neutral |
| Jan-27-26 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-13-26 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-08-26 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-08-25 | Initiated | Wells Fargo | Overweight |
| Jul-08-25 | Resumed | Citigroup | Buy |
| May-15-25 | Downgrade | UBS | Buy → Neutral |
| Apr-08-25 | Downgrade | BofA Securities | Buy → Underperform |
| Oct-23-24 | Upgrade | Argus | Hold → Buy |
| Oct-17-24 | Upgrade | B. Riley Securities | Neutral → Buy |
| Oct-01-24 | Upgrade | BofA Securities | Neutral → Buy |
| Sep-25-24 | Resumed | JP Morgan | Neutral |
| Sep-04-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Aug-12-24 | Upgrade | UBS | Sell → Buy |
| Aug-02-24 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jun-21-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-22-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Jan-16-24 | Initiated | UBS | Sell |
| Dec-07-23 | Initiated | HSBC Securities | Hold |
| Oct-23-23 | Downgrade | BofA Securities | Buy → Neutral |
| Jul-24-23 | Downgrade | Argus | Buy → Hold |
| Jul-14-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-11-23 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Jun-22-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| May-11-23 | Upgrade | Credit Suisse | Neutral → Outperform |
| May-08-23 | Initiated | JP Morgan | Overweight |
| Feb-22-23 | Upgrade | Citigroup | Neutral → Buy |
| Jan-19-23 | Reiterated | B. Riley Securities | Neutral |
| Dec-09-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-07-22 | Initiated | UBS | Neutral |
| Sep-22-22 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Sep-16-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-21-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-08-22 | Downgrade | Credit Suisse | Outperform → Neutral |
| Mar-24-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-11-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Nov-17-21 | Initiated | Wolfe Research | Outperform |
| Nov-02-21 | Upgrade | Jefferies | Hold → Buy |
| Oct-05-21 | Reiterated | JP Morgan | Overweight |
| Sep-29-21 | Reiterated | Morgan Stanley | Overweight |
| Sep-15-21 | Upgrade | Argus | Hold → Buy |
| Jul-16-21 | Upgrade | Citigroup | Neutral → Buy |
| Apr-23-21 | Resumed | JP Morgan | Overweight |
| Mar-24-21 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Mar-17-21 | Upgrade | Deutsche Bank | Hold → Buy |
| Mar-03-21 | Upgrade | Goldman | Sell → Buy |
| Sep-08-20 | Upgrade | BofA Securities | Neutral → Buy |
| Jun-16-20 | Downgrade | Deutsche Bank | Buy → Hold |
| Mar-24-20 | Downgrade | B. Riley FBR | Buy → Neutral |
| Mar-04-20 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jan-17-20 | Upgrade | Deutsche Bank | Hold → Buy |
| Dec-17-19 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Nov-13-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Nov-12-19 | Reiterated | B. Riley FBR | Buy |
| Nov-07-19 | Resumed | Morgan Stanley | Equal-Weight |
| Oct-21-19 | Downgrade | Gabelli & Co | Buy → Hold |
| Sep-26-19 | Reiterated | B. Riley FBR | Buy |
| Sep-23-19 | Downgrade | Goldman | Buy → Neutral |
| Sep-11-19 | Upgrade | Credit Suisse | Neutral → Outperform |
| Aug-16-19 | Reiterated | BofA/Merrill | Neutral |
| Jul-19-19 | Downgrade | Argus | Buy → Hold |
| Jul-11-19 | Downgrade | Deutsche Bank | Buy → Hold |
| Jul-09-19 | Downgrade | Macquarie | Outperform → Neutral |
| Apr-22-19 | Upgrade | Gabelli & Co | Hold → Buy |
| Apr-03-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Apr-02-19 | Downgrade | Credit Suisse | Outperform → Neutral |
View All
Agilent Technologies Inc Stock (AA) Latest News
Price to sales forward of Agilent Technologies, Inc. – MIL:1A - TradingView
Agilent Technologies stock gains as FDA-cleared S540MD slide scanner strengthens digital pathology p - AD HOC NEWS
Agilent Technologies | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
Mikael Dolsten to sell Agilent (NYSE: A) stock - stocktitan.net
Worker says Agilent fired him to mask race and age bias - hcamag.com
Agilent Technologies stock gains on digital pathology launch and strong Q3 figures - AD HOC NEWS
Agilent Expands Digital Pathology Offering with U.S. Launch of the Agilent S540MD Slide Scanner System - 01net
Agilent Technologies Launches FDA-Cleared S540MD Slide Scanner in US - marketscreener.com
Agilent launches FDA-cleared slide scanner in U.S. market By Investing.com - Investing.com Australia
Baird Adjusts Price Target on Agilent Technologies to $180 From $169, Keeps Outperform Rating - marketscreener.com
Agilent Technologies Inc (A) Looks 2.6% Overvalued on GF Value™ - GuruFocus
Agilent: The Recovery Is Real, But So Is The Valuation (NYSE:A) - Seeking Alpha
A SWOT Analysis: Agilent Technologies Inc (A) Reveals Financial Insights in 10-Q Filing - GuruFocus
Bond swap: Agilent (NYSE: A) offers to exchange $600M in 4.9% notes - stocktitan.net
Agilent (NYSE: A) readies global debt program with $100M default triggers - stocktitan.net
Agilent Technologies 3Q 2026: Revenue $1.88B, EPS $1.28— 10-Q Summary - TradingView
Agilent (NYSE: A) spends $950M on Biocare — see how Q3 earnings and debt shifted - stocktitan.net
Agilent Introduces the Cary 635 FTIR Spectrometer - Yahoo Finance
Agilent Technologies, Inc. Introduces The Cary 635 FTIR Spectrometer - marketscreener.com
Agilent launches Cary 635 FTIR spectrometer for laboratories - Investing.com
HSBC Adjusts Price Target on Agilent Technologies to $175 From $165, Maintains Buy Rating - marketscreener.com
AGILENT TECHNOLOGIES INC : HSBC RAISES TARGET PRICE TO $175 FROM $165 - Bitget
International Markets and Agilent (A): A Deep Dive for Investors - Yahoo Finance
Weekly Recap: Agilent (A) Q3 results and pharma reshoring opportunity - TradingView
Stronger Q3 Results and Raised Guidance Could Be A Game Changer For Agilent Technologies (A) - Sahm
Agilent Technologies Inc. stock underperforms Friday when compared to competitors - MarketWatch
Wells Fargo Adjusts Price Target on Agilent Technologies to $180 From $160, Keeps Overweight Rating - Moomoo
Agilent (NYSE) Expanded Non-GAAP Margin 320 bps. How Much Is Repeatable? - Yahoo Finance
Rothschild & Co Redburn Adjusts Agilent Technologies Price Target to $180 From $160, Maintains Buy Rating - Moomoo
Agilent Technologies: Q3 Growth, Expanding Margins, And Raised Guidance - Seeking Alpha
Agilent Technologies beats estimates, raises guidance on strong demand; shares up - Investing.com
AGILENT TECHNOLOGIES INC : RBC RAISES TARGET PRICE TO $185 FROM $155 - Bitget
Agilent Technologies Q3 Earnings Call Highlights - Yahoo Finance
Transcript : Agilent Technologies, Inc., Q3 2026 Earnings Call, Aug 26, 2026 - marketscreener.com
Is Agilent Technologies Inc (A) Overvalued After Q3 Earnings? EP - GuruFocus
Agilent: Fiscal Q3 Earnings Snapshot - 10TV
Agilent Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2026 - marketscreener.com
Agilent Reports Third-Quarter Fiscal Year 2026 Financial Results - Business Wire
Agilent Technologies (A) is a Great Momentum Stock: Should You Buy? - Yahoo Finance
Agilent Technologies Slides Ahead of Earnings as Investors Appear Cautious - Moomoo
Agilent Technologies Inc. Stock Slips 3.5%, Underperforms Peers - Bitget
Why Agilent Technologies (A) Is Up 7.0% After Q2 Beat And Higher 2026 GuidanceAnd What's Next - simplywall.st
Agilent Technologies stock hits 52-week high at 160.36 USD - Investing.com
Agilent Stock Has A Catalyst Coming On August 26 That Investors Should Not Ignore - 24/7 Wall St.
Exploring Analyst Estimates for Agilent (A) Q3 Earnings, Beyond Revenue and EPS - Yahoo Finance
Agilent Technologies (A) Q3 2026 Preview: EPS Est. $1.44, Reports August 26 - AlphaStreet
Agilent Technologies stock trades close to 12?month high as guidance and analyst consensus support o - Ad-hoc-news.de
Agilent Technologies stock gains after fresh analyst target lift and regulatory filing - Ad-hoc-news.de
A5143230 Bond Profile — Key Metrics - TradingView
What Are Wall Street Analysts' Target Price for Agilent Technologies Stock? - inkl
Agilent Technologies (A) Gains Attention In Cannabis Testing, Is It Fully Valued? - simplywall.st
Agilent Technologies Inc Stock (AA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.39%
1.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):